{"url":"https://lda.senate.gov/api/v1/filings/e5173e7c-0fb9-4be4-925c-e9c18042f5ce/","filing_uuid":"e5173e7c-0fb9-4be4-925c-e9c18042f5ce","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/e5173e7c-0fb9-4be4-925c-e9c18042f5ce/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Michael Liszewski","dt_posted":"2026-05-21T22:01:03-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1319 Maryland Ave NE","registrant_address_2":"Apt. B","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":401109612,"url":"https://lda.senate.gov/api/v1/registrants/401109612/","house_registrant_id":77143,"name":"ENACT CONSULTING, LLC","description":null,"address_1":"1319 Maryland Ave NE","address_2":"Apt. B","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20002","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL LISZEWSKI","contact_telephone":"+1 202-262-8857","dt_updated":"2026-07-28T12:08:15.075230-04:00"},"client":{"id":68101,"url":"https://lda.senate.gov/api/v1/clients/68101/","client_id":68101,"name":"DRUG POLICY ALLIANCE","general_description":"Drug policy reform","client_government_entity":null,"client_self_select":false,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-07-01"},"lobbying_activities":[{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Federal marijuana reform, primarily descheduling legislation, such as the MORE Act and CAOA, as well as narrower related legislation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150868,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"LISZEWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}